Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription


2 Acta Neuropathol
1 Alzheimer Dis Assoc Disord
8 Alzheimers Dement
1 Ann Neurol
1 BMC Geriatr
1 Brain
2 Curr Alzheimer Res
1 Curr Opin Neurol
2 Exp Neurol
19 J Alzheimers Dis
1 J Biol Chem
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 Nat Rev Neurosci
1 Nature
3 Neurobiol Dis
2 Neurochem Res
1 Neurology
2 Neurosci Lett

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neuropathol

  1. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
    CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2024;147:12.
    PubMed         Abstract available

  2. VAN DER GAAG BL, Deshayes NAC, Breve JJP, Bol JGJM, et al
    Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
    Acta Neuropathol. 2024;147:14.
    PubMed         Abstract available

    Alzheimer Dis Assoc Disord

  3. WERNER P, Ulitsa N, Alpinar-Sencan Z, Shefet D, et al
    Identifying Stigmatizing Language Used by Israelis and Germans With a Mild Neurocognitive Disorder, Their Relatives, and Caregivers of People With Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2024 Jan 9. doi: 10.1097/WAD.0000000000000596.
    PubMed         Abstract available

    Alzheimers Dement

  4. HATA Y, Nakase M, Ichimata S, Yoshida K, et al
    Neuropathology of patients with preclinical or early clinical Alzheimer's disease with pathogenic PSEN1_p. L392V: Comparison of advanced siblings.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13675.
    PubMed         Abstract available

  5. SUCHY-DICEY AM, Longstreth WT Jr, Rhoads K, Umans J, et al
    Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13664.
    PubMed         Abstract available

  6. HO PC, Yu WH, Tee BL, Lee WP, et al
    Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13611.
    PubMed         Abstract available

  7. OWENS HA, Thorburn LE, Walsby E, Moon OR, et al
    Alzheimer's disease-associated P460L variant of EphA1 dysregulates receptor activity and blood-brain barrier function.
    Alzheimers Dement. 2024 Jan 7. doi: 10.1002/alz.13603.
    PubMed         Abstract available

  8. WANG P, Lynn A, Miskimen K, Song YE, et al
    Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 7. doi: 10.1002/alz.13655.
    PubMed         Abstract available

  9. BUTO PT, Wang J, La Joie R, Zimmerman SC, et al
    Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13610.
    PubMed         Abstract available

  10. GU Y, Honig LS, Kang MS, Bahl A, et al
    Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13652.
    PubMed         Abstract available

  11. JIANG Y, Uhm H, Ip FC, Ouyang L, et al
    A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13676.
    PubMed         Abstract available

    Ann Neurol

  12. VANCE JM, Farrer LA, Huang Y, Cruchaga C, et al
    Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease.
    Ann Neurol. 2024 Jan 5. doi: 10.1002/ana.26864.
    PubMed         Abstract available

    BMC Geriatr

  13. SABATINI S, Martyr A, Hunt A, Gamble LD, et al
    Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme.
    BMC Geriatr. 2024;24:23.
    PubMed         Abstract available


  14. QIN C, Chen M, Dong MH, Yang S, et al
    Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
    Brain. 2024;147:163-176.
    PubMed         Abstract available

    Curr Alzheimer Res

  15. MA W, Lu K, Liang HM, Zhang JY, et al
    Synapsin 1 Ameliorates Cognitive Impairment and Neuroinflammation in Rats with Alzheimer's Disease: An Experimental and Bioinformatics Study.
    Curr Alzheimer Res. 2024 Jan 11. doi: 10.2174/0115672050276594231229050906.
    PubMed         Abstract available

  16. GREEN ZD, Kueck PJ, John CS, Burns JM, et al
    Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant.
    Curr Alzheimer Res. 2023;20:557-566.
    PubMed         Abstract available

    Curr Opin Neurol

  17. SMITH PF
    Aging of the vestibular system and its relationship to dementia.
    Curr Opin Neurol. 2024;37:83-87.
    PubMed         Abstract available

    Exp Neurol

  18. YUBOLPHAN R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, et al
    Potential links between platelets and amyloid-beta in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies.
    Exp Neurol. 2024 Jan 9:114683. doi: 10.1016/j.expneurol.2024.114683.
    PubMed         Abstract available

  19. XU M, Li J, Xia L, Du Y, et al
    PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation.
    Exp Neurol. 2024 Jan 10:114688. doi: 10.1016/j.expneurol.2024.114688.
    PubMed         Abstract available

    J Alzheimers Dis

  20. AHMED T, Zhang P, Kumar K
    Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
    J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
    PubMed         Abstract available

  21. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
    Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
    J Alzheimers Dis. 2024;97:219-228.
    PubMed         Abstract available

  22. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
    Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
    J Alzheimers Dis. 2024;97:345-358.
    PubMed         Abstract available

  23. GUO Y, Sun Y, Li M, Qi WY, et al
    Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
    J Alzheimers Dis. 2024;97:471-484.
    PubMed         Abstract available

  24. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
    Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:171-178.
    PubMed         Abstract available

  25. MARTIN J, Reid N, Ward DD, King S, et al
    Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
    J Alzheimers Dis. 2024;97:101-119.
    PubMed         Abstract available

  26. YANG M, Gan J, Liu S, Yang Y, et al
    Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
    J Alzheimers Dis. 2024;97:409-419.
    PubMed         Abstract available

  27. KIM REY, Lee M, Kang DW, Wang SM, et al
    Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    J Alzheimers Dis. 2024;97:259-271.
    PubMed         Abstract available

  28. NA S, Lee C, Ho S, Hong YJ, et al
    A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
    J Alzheimers Dis. 2024;97:193-204.
    PubMed         Abstract available

  29. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
    The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
    J Alzheimers Dis. 2024;97:179-191.
    PubMed         Abstract available

  30. BRUNO JL, Shaw JS, Hosseini SMH
    Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
    J Alzheimers Dis. 2024;97:327-343.
    PubMed         Abstract available

  31. FAN X, Cai Y, Zhao L, Liu W, et al
    Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
    PubMed         Abstract available

  32. ZHANG C, Lei X, Ma W, Long J, et al
    Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
    PubMed         Abstract available

  33. SELLES MC, Oliveira MM
    The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
    PubMed         Abstract available

  34. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
    The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
    J Alzheimers Dis. 2024;97:507-519.
    PubMed         Abstract available

  35. ZENG Y, Cao S, Pang K, Tang J, et al
    Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2024;97:229-237.
    PubMed         Abstract available

  36. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
    Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
    J Alzheimers Dis. 2024;97:309-325.
    PubMed         Abstract available

  37. The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
    J Alzheimers Dis. 2024;97:1.

  38. NADEAU PA, Jobin B, Boller B
    Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;97:521.

    J Biol Chem

  39. KOMMADDI RP, Gowaikar R, Pa H, Diwakar L, et al
    Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer's disease mouse model.
    J Biol Chem. 2024 Jan 3:105619. doi: 10.1016/j.jbc.2023.105619.
    PubMed         Abstract available

    J Neurol

  40. HENNEY AE, Gillespie CS, Alam U, Hydes TJ, et al
    High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies.
    J Neurol. 2024;271:198-210.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  41. KEUSS SE, Coath W, Cash DM, Barnes J, et al
    Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with beta-amyloid status in cognitively normal adults at age 70.
    J Neurol Neurosurg Psychiatry. 2024 Jan 10:jnnp-2023-332067.
    PubMed         Abstract available

    Nat Rev Neurosci

  42. BLUMENFELD J, Yip O, Kim MJ, Huang Y, et al
    Cell type-specific roles of APOE4 in Alzheimer disease.
    Nat Rev Neurosci. 2024 Jan 8. doi: 10.1038/s41583-023-00776.
    PubMed         Abstract available


  43. IRVING-PEASE EK, Refoyo-Martinez A, Barrie W, Ingason A, et al
    The selection landscape and genetic legacy of ancient Eurasians.
    Nature. 2024;625:312-320.
    PubMed         Abstract available

    Neurobiol Dis

  44. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    PubMed         Abstract available

  45. PIETILA E, Snellman A, Tuisku J, Helin S, et al
    Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation - A 5-year follow-up [(11)C]PIB-PET study.
    Neurobiol Dis. 2024;190:106385.
    PubMed         Abstract available

  46. GHARPURE M, Vyavahare S, Ahluwalia P, Gupta SK, et al
    Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology.
    Neurobiol Dis. 2024;191:106404.
    PubMed         Abstract available

    Neurochem Res

  47. NADERI S, Motamedi F, Pourbadie HG, Rafiei S, et al
    Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca(2+) Channels in the Dentate Gyrus Granular Cells.
    Neurochem Res. 2024;49:99-116.
    PubMed         Abstract available

  48. TAKANO-KAWABE K, Matoba K, Nakamura Y, Moriyama M, et al
    Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia.
    Neurochem Res. 2024;49:199-211.
    PubMed         Abstract available


  49. CHOLERTON B, Latimer CS, Crane PK, Corrada MM, et al
    Neuropathologic Burden and Dementia in Nonagenarians and Centenarians.
    Neurology. 2024;102:e208060.
    PubMed         Abstract available

    Neurosci Lett

  50. XIE YH, Jiang L, Zhang Y, Deng YH, et al
    Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
    Neurosci Lett. 2024;820:137612.
    PubMed         Abstract available

  51. ROBBIE L, Fernandez SG, Montoya L, Sagare A, et al
    Age of onset predicted by Abeta profiling in a novel PSEN1 (I180F) mutation.
    Neurosci Lett. 2024;820:137591.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.